Difference between revisions of "AML Copy Number Profile"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| (8 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | {{#iDisplay:http://54.191.11.12/AML.html}} | + | __TOC__ |
| + | |||
| + | == Copy Number Losses == | ||
| + | |||
| + | *[[MDS/AML with CUX1 deletion or del(7q22)|Deletion (7q22) in AML]] | ||
| + | *[[Deletion (7) in AML]] | ||
| + | *[[Deletion (17p) in AML]] | ||
| + | |||
| + | == Copy Number Gains == | ||
| + | |||
| + | *[[Gain (8) in AML]] | ||
| + | |||
| + | == Amplifications == | ||
| + | |||
| + | None known. | ||
| + | |||
| + | == Structural Rearrangements == | ||
| + | |||
| + | #[[Translocation t(3;3)(q21;q26.2) and Inversion inv(3)(q21q26.2)|Translocation t(3;3)(q21;q26.2) and Inversion inv(3)(q21q26.2) RPN1-MECOM]] | ||
| + | #[[Acute Myeloid Leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1|Translocation t(8;21)(q22;q22) RUNX1-RUNX1T1]] | ||
| + | #[[Translocation t(6;9)(p23;q34)|Translocation t(6;9)(p23;q34) DEK-NUP214]] | ||
| + | #[[Acute_Myeloid_Leukemia_with_inv(16)(p13.1q22)_or_t(16;16)(p13.1;q22); CBFB-MYH11|Inversion inv(16)(p13.1q22) or translocation t(16;16)(p13.1;q22) CBFB-MYH11]] | ||
| + | |||
| + | == TCGA Copy Number Profile == | ||
| + | |||
| + | {{#iDisplay:http://54.191.11.12/AML.html|1200}} | ||
Latest revision as of 08:40, 17 August 2016
Copy Number Losses
Copy Number Gains
Amplifications
None known.
Structural Rearrangements
- Translocation t(3;3)(q21;q26.2) and Inversion inv(3)(q21q26.2) RPN1-MECOM
- Translocation t(8;21)(q22;q22) RUNX1-RUNX1T1
- Translocation t(6;9)(p23;q34) DEK-NUP214
- Inversion inv(16)(p13.1q22) or translocation t(16;16)(p13.1;q22) CBFB-MYH11
TCGA Copy Number Profile
{{#iDisplay:http://54.191.11.12/AML.html%7C1200}}